New 52 Week High Today

Lonza Group AG LON.N-CH:Swiss Exchange

*Data is delayed | CHF
Last | 5:30 PM CEST
664.60quote price arrow up+3.00 (+0.45%)
Volume
164,231
52 week range
458.60 - 667.00

...

Loading . . .
  • Open664.40
  • Day High667.00
  • Day Low661.20
  • Prev Close661.60
  • 52 Week High667.00
  • 52 Week High Date06/14/21
  • 52 Week Low458.60
  • 52 Week Low Date06/15/20

Key Stats

  • Market Cap54,728.14M
  • Shares Out74.28M
  • 10 Day Average Volume216,594.33
  • Dividend3.00
  • Dividend Yield0.45%
  • Beta0.02
  • YTD % Change16.84

KEY STATS

  • Open664.40
  • Day High667.00
  • Day Low661.20
  • Prev Close661.60
  • 52 Week High667.00
  • 52 Week High Date06/14/21
  • 52 Week Low458.60
  • 52 Week Low Date06/15/20
  • Market Cap54,728.14M
  • Shares Out74.28M
  • 10 Day Average Volume216,594.33
  • Dividend3.00
  • Dividend Yield0.45%
  • Beta0.02
  • YTD % Change16.84

RATIOS/PROFITABILITY

  • EPS (TTM)11.63
  • P/E (TTM)57.15
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Lonza Group AG

There is no recent news for this security.

Profile

MORE
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics...
Albert Baehny
Chairman
Pierre-Alain Ruffieux Ph.D.
Chief Executive Officer
Rodolfo Savitzky
Chief Financial Officer
Address
Muenchensteinerstrasse 38
Basel
4002
Switzerland